SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Generate Biomedicines and Zealand Pharma enter collaboration and license agreement

The agreement covers development of AI-engineered protein therapeutics for metabolic diseases.

GENB

Story updates

08:32:36 PM UTC
SquawkNews
Generate Biomedicines And Zealand Pharma Enter Collaboration And License Agreement To Develop Protein Therapeutics Engineered With Ai For Metabolic Diseases